Chemokine Therapeutics Corp.
This article was originally published in Start Up
Executive Summary
Cytokines, immune-system actors first discovered in the 1980s, have been developed into some very important drugs--like Amgen's blockbuster erythropoietin (Neupogen). Now Chemokine Therapeutics Corp. is seeking to develop peptides that mimic or antagonize a member of a subclass of these proteins known as chemokines. The lead candidate may help protect patients' stem cells from the destructive power of chemotherapy.